Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > Leading chronic cough expert joins AGN advisory board

View:

Post by XeniaTechie on Jan 13, 2023 2:15pm

Leading chronic cough expert joins AGN advisory board

The appointment of Dr. Peter Dicpinigaitis MD as a medical consultant to Algernon Pharmaceuticals' chronic cough research program is pretty significant. Dr. Dicpinigaitis is the founder and director of the Montefiore Cough Center, one of the few specialty centers in the world exclusively committed to the evaluation and management of patients with chronic cough. He’s authored many peer-reviewed journal articles and book chapters on cough and is considered an authority on the performance of cough challenge studies in clinical research. He also serves as the Editor-in-Chief of the journal LUNG. His expertise will be valuable to the company as they advance towards their upcoming Phase 2b chronic cough study of NP-120 (Ifenprodil). https://www.globenewswire.com/news-release/2023/01/11/2586904/0/en/Algernon-Pharmaceuticals-Appoints-Dr-Peter-Dicpinigaitis-to-Chronic-Cough-Advisory-Board.html

132